Rare Diseases: Medical Treatments

Department of Health written question – answered on 14th September 2017.

Alert me about debates like this

Photo of Michelle Donelan Michelle Donelan Conservative, Chippenham

To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the NICE process for reviewing new treatments for rare diseases.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary of State for Health

The National Institute for Health and Care Excellence is the independent, expert body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources. The methods and processes it uses in the development of its guidance are internationally respected and have been developed through extensive engagement with a full range of stakeholders, including the Department, and are periodically reviewed to ensure that they remain fit for purpose.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.